Renin-Angiotensin System Inhibitors, Type 2 Diabetes and Fibrosis Progression: An Observational Study in Patients with Nonalcoholic Fatty Liver Disease

A “systems medicine” approach to the study of non-alcoholic fatty liver disease

(2016) Salvatore Petta et al.   DIGESTIVE AND LIVER DISEASE

MERTK rs4374383 polymorphism affects the severity of fibrosis in non-alcoholic fatty liver disease

(2016) Salvatore Petta et al.   JOURNAL OF HEPATOLOGY

Obesity-Induced Hypertension: Interaction of Neurohumoral and Renal Mechanisms

(2015) J. E. Hall et al.   CIRCULATION RESEARCH

Fibrosis Progression in Nonalcoholic Fatty Liver vs Nonalcoholic Steatohepatitis: A Systematic Review and Meta-analysis of Paired-Biopsy Studies

(2015) Siddharth Singh et al.   Clinical Gastroenterology and Hepatology

Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease

(2015) Paul Angulo et al.   GASTROENTEROLOGY

Peripheral insulin resistance predicts liver damage in nondiabetic subjects with nonalcoholic fatty liver disease

(2015) Chiara Rosso et al.   HEPATOLOGY

Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease

(2015) Paola Dongiovanni et al.   HEPATOLOGY

Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up

(2015) Mattias Ekstedt et al.   HEPATOLOGY

Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: Implications for prognosis and clinical management

(2015) Stuart McPherson et al.   JOURNAL OF HEPATOLOGY

Statin use and non-alcoholic steatohepatitis in at risk individuals

(2015) Paola Dongiovanni et al.   JOURNAL OF HEPATOLOGY

Renin-angiotensin system and fibrosis in non-alcoholic fatty liver disease

(2014) George B Goh et al.   LIVER INTERNATIONAL

Nonalcoholic fatty liver disease and the renin-angiotensin system blockers in the patients with chronic kidney disease

(2014) Lidija Orlic et al.   WIENER KLINISCHE WOCHENSCHRIFT

A randomized trial of iron depletion in patients with nonalcoholic fatty liver disease and hyperferritinemia

(2014) Luca Valenti   WORLD JOURNAL OF GASTROENTEROLOGY

A systematic review of follow-up biopsies reveals disease progression in patients with non-alcoholic fatty liver

(2013) Raluca Pais et al.   JOURNAL OF HEPATOLOGY

The role of angiotensin II in nonalcoholic steatohepatitis

(2012) E. Matthew Morris et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Olmesartan severely weakened the development of NASH in an animal model of hypercholesterolemia

(2011) Mário Cláudio Soares Sturzeneker et al.   ATHEROSCLEROSIS

Rosiglitazone versus rosiglitazone and metformin versus rosiglitazone and losartan in the treatment of nonalcoholic steatohepatitis in humans: A 12-month randomized, prospective, open- label trial

(2011) Dawn M. Torres et al.   HEPATOLOGY

Iron in fatty liver and in the metabolic syndrome: A promising therapeutic target

(2011) Paola Dongiovanni et al.   JOURNAL OF HEPATOLOGY

Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: A role for insulin resistance and diabetes

(2008) Anna Ludovica Fracanzani et al.   HEPATOLOGY